HIGHBRIDGE CAPITAL MANAGEMENT LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2017$12,220,000
+1723.9%
874,171
+1053.3%
0.18%
+1730.0%
Q2 2017$670,000
+33.2%
75,800
-2.5%
0.01%
+42.9%
Q1 2017$503,000
+349.1%
77,740
+233.2%
0.01%
+600.0%
Q4 2014$112,000
-30.4%
23,334
-46.1%
0.00%
-50.0%
Q3 2014$161,000
-42.5%
43,266
-28.9%
0.00%
-33.3%
Q4 2013$280,000
-45.5%
60,890
-26.6%
0.00%
-40.0%
Q3 2013$514,00082,9000.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders